/EVIO
EVIO Stock - EVIO, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for EVIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta81.01
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $1.59M | $2.36M | $3.60M | $3.79M | $3.37M |
| Gross Profit | $525,000 | $332,000 | $58,000 | $-936,040 | $-471,763 |
| Gross Margin | 33.0% | 14.0% | 1.6% | -24.7% | -14.0% |
| Operating Income | $-1,384,000 | $-3,778,000 | $-4,215,670 | $296,994 | $-8,176,424 |
| Net Income | $48,000 | $-965,000 | $-8,415,088 | $-20,669,033 | $-11,634,091 |
| Net Margin | 3.0% | -40.8% | -234.0% | -545.4% | -345.7% |
| EPS | $0.00 | $-0.00 | $-0.12 | $-0.77 | $-0.70 |
Company Overview
EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
EVIOBeat Rate
0%
Last 1 quarters
Avg Surprise
-111.1%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.04
Q2 2020
EPS Surprise History
Q3 18
No data
Q4 18
No data
Q2 19
No data
Q2 19
No data
Q3 19
No data
Q4 19
No data
Q1 20
No data
Q2 20
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2020 | Jun 30, 2020 | — | $-0.04 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.09 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.10 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.44 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.05 | — | — |
Q2 2019 | May 17, 2019 | — | $-0.15 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.10 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.27 | — | — |
Q3 2018 | Aug 14, 2018 | $-0.09 | $-0.19 | -111.1% | ✗ MISS |
Q2 2018 | May 16, 2018 | — | $-0.11 | — | — |
Q1 2018 | Feb 13, 2018 | — | $-0.08 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.16 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.06 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.05 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.09 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.20 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.08 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.08 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.02 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.09 | — | — |
Latest News
Loading news...
Frequently Asked Questions about EVIO
What is EVIO's current stock price?
EVIO, Inc. (EVIO) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for EVIO?
No analyst price targets are currently available for this stock.
What sector is EVIO, Inc. in?
EVIO, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is EVIO's market cap?
EVIO, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does EVIO pay dividends?
No, EVIO, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTCF
Aion Therapeutic Inc.
$0.00
Mkt Cap: $0.0B
BSPK
Bespoke Extracts, Inc.
$0.20
Mkt Cap: $0.0B
FWDG
FutureWorld Corp.
$0.00
Mkt Cap: $0.0B
HEMP
Hemp, Inc
$0.00
Mkt Cap: $0.0B
JWCAF
James E. Wagner Cultivation Corporation
$0.00
Mkt Cap: $0.0B
KAYS
Kaya Holdings, Inc.
$0.04
Mkt Cap: $0.0B
KHRNF
Khiron Life Sciences Corp.
$0.00
Mkt Cap: $0.0B
LVRLF
CordovaCann Corp.
$0.03
Mkt Cap: $0.0B
PBFFF
Planet Based Foods Global Inc.
$0.05
Mkt Cap: $0.0B
SHMN
SOHM, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to EVIO for comparison